Series B Therapeutics Companies

Cellics is committed to saving lives and improving patients’ health using innovative biomimetic nanomedicines.

Skin + Me is a D2C brand providing personalized skin treatments for feel-great skin.

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

Arkuda Therapeutics is a pharmaceutical company.

PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.

VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.

Peptilogics is a clinical-stage therapeutics company that develops peptide-based therapeutics using AI and computational biology.

BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules.

Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.

Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.

Xanadu Bio is a nanoparticle delivery company focusing on the delivery of mRNA and other nucleic acids that uses PACE platform technology.

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.

Cartwheel offers mental health support to students in order to help schools regain balance in the midst of the student mental health crisis.

Technology-driven infusion therapy company

Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.

Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.

Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.

Ace Vision Group develop laser-based therapeutic technologies to heal age-related eye dysfunction and restore the eye's natural performance.

Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.

Gallant is advancing investigational stem cell therapies to help give pets more good years, making regenerative care more accessible.

Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.

Ashvattha Therapeutics is a clinical-stage biopharmaceutical company that develops precision nanomedicines for ophthalmology diseases.